Literature DB >> 438479

WAIS performance for different age groups of hypertensive and control subjects during the administration of a diuretic.

N R Schultz, J T Dineen, M F Elias, C A Pentz, W G Wood.   

Abstract

This study examined the effects of age and hypertension on WAIS performance. Previous studies have reported that hypertension adversely affects cognitive functioning, but few have considered the influence of hypertension on discrete age groups. Hypertension was found to be negatively associated with WAIS Verbal scores for younger (21 to 39 years) but not older (45 to 65 years) subjects. Further, younger subjects attained higher WAIS Performance scores than did older subjects. Medication history was not associated with performance levels for hypertensives, nor was performance of controls influenced by whether or not they were tested while on a diuretic. When WAIS Performance scores were analyzed for subjects matched on WAIS Verbal scores across age (21 to 39 vs 45 to 65 years) and blood pressure (normotensive vs hypertensive), a significant age by blood pressure interaction was found. The effect of blood pressure on Performance scores was found to be greater for younger than for older subjects. The association between plasma renin activity (PRA) level and WAIS Performance scores was also examined. Contrary to previous findings PRA was not related to Performance scores. The results are discussed in the context of previous hypertension research and their implications for comparisons across age levels.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 438479     DOI: 10.1093/geronj/34.2.246

Source DB:  PubMed          Journal:  J Gerontol        ISSN: 0022-1422


  11 in total

1.  Assessment of quality of life in cardiovascular therapy.

Authors:  A E Fletcher; C J Bulpitt
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

2.  The effects of two centrally-acting anti-hypertensive drugs on the quality of life.

Authors:  A E Fletcher; D G Beevers; C T Dollery; R Wilkinson; C J Bulpitt
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  The effects of ACE inhibitors on cognitive function.

Authors:  A A O'Brien; C J Bulpitt
Journal:  Drugs Aging       Date:  1995-03       Impact factor: 3.923

Review 4.  Psychomotor performance and antihypertensive treatment.

Authors:  L Kalra; C G Swift; S H Jackson
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

Review 5.  Hypertension: cognitive and behavioral considerations.

Authors:  H E King; R E Miller
Journal:  Neuropsychol Rev       Date:  1990-03       Impact factor: 7.444

6.  The effects of mild diastolic hypertension on the results of tests of cognitive function in adults 22 to 59 years of age.

Authors:  E J Pérez-Stable; T J Coates; R Halliday; P S Gardiner; W W Hauck
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

7.  Phaeochromocytoma as a cause of reversible dementia.

Authors:  P D White; W A Lishman; M A Wyke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-12       Impact factor: 10.154

8.  Central effects of the diuretic, bendrofluazide.

Authors:  D G McDevitt; D Currie; A N Nicholson; N A Wright; M B Zetlein
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335

9.  The association between hypertension treatment, control, and functional status.

Authors:  D S Siscovick; D S Strogatz; S W Fletcher; B Leake; R H Brook
Journal:  J Gen Intern Med       Date:  1987 Nov-Dec       Impact factor: 5.128

10.  Hypertension and cognitive function.

Authors:  L R Grossman; C Zalewski
Journal:  J Clin Psychol Med Settings       Date:  1995-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.